Here's a review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment.
All News
Article
Pregnancy Outcomes in AxSpa: Dr. Robert Chao ( @doctorRBC) reviews abstracts #1498, #1323 and #1324 presented at the #ACR20.
https://t.co/0N0FJh2WZd https://t.co/tbQjojlanu
The EMA's CHMP has recommended upadacitinib (Rinvoq) as an indication for the treatment of adults with active Psoriatic Arthritis and Ankylosing Spondylitis. https://t.co/0PKm90mo7F
Delays in Diagnosis - Axial Spondyloarthritis: Dr Antoni Chan ( @synovialjoints) reviews abstracts #1303 and #1306 presented at the #ACR20.
https://t.co/k7L2ebXcGb https://t.co/6oQ8fWpVCQ
#BestACR20Tweets RT @KDAO2011 : #FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed
Revisit #ACR20 through our podcast!
Best Practices for APL Testing,
Is COVID19 infection bad for rheumatic disease patients?
Pregnancy in SpA Patients
A New Pathway (Deucravacitinib) in Psoriatic Arthritis
https://t.co/kmoOL4d3oF https://t.co/qQQd1aJm8K
#BestACR20Tweets
RT @doctorRBC : AxSpa pts had Significant Gut Microbiome Differences in:
1⃣Disease activity and duration
2⃣Enthesitis
3⃣Radiographic involvement
Abs#1853 https://t.co/ynemrgsP3W
Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis ( @RADoctor) reviews abstract #1444 at #ACR20.
https://t.co/4tqWuzwn54 https://t.co/u0vn4d1yF8
#BestACR20Tweets
RT @uptoTate : Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/vWjvAEeDMi https://t.co/HdMKSkkJ8I
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20
https://t.co/ePrhQ90kwD
Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20
https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul
New Treatments in Axial Spondyloarthritis: Dr. Antoni Chan ( @synovialjoints) discuses two abstracts presented at the #ACR20 annual meeting.
https://t.co/bh7l6C8p7P https://t.co/RN60iWCmet
Dr. Conway ( @RichardPAConway) and Dr. Maguire discuss abstract #1323 presented at the #ACR20 on pregnancy in Spondyloarthritis.
https://t.co/YyWOuiq3jn https://t.co/SnodUbKZTx
SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup by Dr. Robert Chao ( @doctorRBC) #ACR20
https://t.co/wR0inoR8jp https://t.co/7SFkThkPSr
#BestACR20Tweets
RT @doctorRBC : Gender disparity in Ankylosing Spondylitis symptoms.
1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use
2⃣HLA-B not associated w/ enthesitis
@RheumNow #ACR20 Abs#1872 https://t.co/pBcpuqgq0K https://t.co/YWKFUdIgMl
#BestACR20Tweets
RT @ejdein1 : #ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/knduk3l6xV https://t.co/SNommxn1jA
Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler #ACR20
https://t.co/zql7iySXOA https://t.co/PY9k108QTc
#BestACR20Tweets
RT @DrPetryna : #ACR20 abs1535 retrospective study of SI MRI reveals 20% pts w/out spondyloarthritis have BME on an MRI, predominantly in the antero-middle quadrant. Erosions were seen in 31% of healthy patients and in 61% of patients with spondyloarthritis


